Phenotypic manifestations of insulin-like growth factor binding protein-1 (IGFBP-1) and IGFBP-3 overexpression in transgenic mice

Abstract

To provide further insight into the function of the IGFBPs, transgenic (Tg) mice which overexpressed IGFBP-1 and IGFBP-3 were generated. In this report we have compared the phenotypic manifestations observed in these Tg mice. The IGFBP-1 Tg mice were significantly smaller at birth, birth weight and gained less weight in the postnatal period. Organ weight was proportionately reduced relative to body weight in most organs. However the brain was markedly smaller in IGFBP-1 Tg mice. Mean plasma levels of Tg-derived IGFBP-1 ranged from 8 to 80 ng ml −1 in the different groups of IGFBP-1 Tg mice. In addition homozygous mice also demonstrated fasting hyperglycemia, impaired glucose tolerance and reduced fecundity. Two of the seven IGFBP-3 founders had measurable levels of hlGFBP-3 in the circulation and were bred to homozygosity. Maximal plasma levels of transgene-derived IGFBP-3 were 72–198 ng ml −1. Transgene expression was detected in the kidney, small intestine and colon by Northern blot analysis. The birth weight, litter size and body weight of IGFBP-3 Tg mice were not significantly different from wild-type mice. However, the spleen, liver and heart of IGFBP-3 Tg mice derived from both founders were significantly heavier compared with organs from wild-type mice. The relative weight of other organs such as the brain, kidney and lungs were similar to wild-type mice. From these data, we conclude that over expression of IGFBP-1 results in inhibition of IGF action and in profound impairment of brain development, modest inhibition of fetal and postnatal growth and inhibition of the metabolic effects of the IGFs. In contrast, modest overexpression of hlGFBP-3 has little effect other than some selective organomegaly.